CRBU
Caribou Biosciences Inc
1.20$
-2.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -53.1% | -4.1% | +20.6% | +37.5% | +0.6% | -1.6% | +0.2% | -45.9% | +8.1% | -4.8% | -3.7% | – | |
| – | +2.2% | +12.1% | +18.8% | -14.1% | -3.9% | -0.7% | -19.4% | -6.3% | -6.6% | -13.9% | +5.1% | – | |
| – | – | -116.9% | – | -198.7% | – | – | – | -354.3% | – | -365.2% | – | – | |
| – | -52.1% | +29.5% | -19.7% | -71.6% | -23.0% | +101.2% | -59.9% | -72.5% | +87.8% | -66.7% | -98.6% | – | |
| – | -54.0% | – | -7.6% | +25.1% | -39.9% | +210.0% | -51.3% | -54.9% | +65.6% | +33.5% | -21.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -98.9% | +84.8% | +1,483.2% | -87.9% | -98.7% | +4,516.7% | +1,369.3% | -33.8% | +565.3% | – | |
| – | -239.7% | – | – | – | – | – | -132.1% | – | – | -124.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.